mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
BRD-A05715709 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.1 |
mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
BEC |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.1 |
mRNA |
AZ628 |
GDSC1000 |
pan-cancer |
AAC |
0.075 |
0.1 |
mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
-0.054 |
0.1 |
mRNA |
Parthenolide |
GDSC1000 |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
Vinorelbine |
GDSC1000 |
pan-cancer |
AAC |
-0.053 |
0.1 |
mRNA |
RDEA119 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.1 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |